Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Rex

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2012
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trialsDavid R Andes, Nasia Safdar, John W Baddley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndromeZekaver Odabasi, Gloria Mattiuzzi, Elihu Estey, et al.
The Journal of Infectious Diseases|May 6, 2017
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet NeedsHelen W Boucher, Paul G Ambrose, H F Chambers, et al.
Annals of Internal Medicine|July 16, 2008
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trialMindy G Schuster, John E Edwards, Jack D Sobel, et al.
Mbio|August 24, 2017
Pharmacodynamics of the Orotomides against <i>Aspergillus fumigatus</i>: New Opportunities for Treatment of Multidrug-Resistant Fungal DiseaseWilliam W Hope, Laura McEntee, Joanne Livermore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2002
Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective studyElias J Anaissie, Shawna L Stratton, M Cecilia Dignani, et al.
The Lancet. Infectious Diseases|January 22, 2013
A comprehensive regulatory framework to address the unmet need for new antibacterial treatmentsJohn H Rex, Barry I Eisenstein, Jeff Alder, et al.
The Lancet. Infectious Diseases|September 28, 2013
Addressing the need for new antibacterials--authors' replyJohn H Rex, Barry I Eisenstein, Jeff Alder, et al.
Medical Mycology|February 20, 2026
Rhino-sino-orbital and/or central nervous system infections due to Lomentospora prolificans and Scedosporium spp. in onco-haematology patientsEnric Sastre-Escolà, Michelle K Yong, Shio Yen Tio, et al.
The Journal of Infectious Diseases|January 17, 2019
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial PneumoniaGeorge H Talbot, Anita Das, Stephanie Cush, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2012
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trialsDavid R Andes, Nasia Safdar, John W Baddley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndromeZekaver Odabasi, Gloria Mattiuzzi, Elihu Estey, et al.
The Journal of Infectious Diseases|May 6, 2017
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet NeedsHelen W Boucher, Paul G Ambrose, H F Chambers, et al.
Annals of Internal Medicine|July 16, 2008
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trialMindy G Schuster, John E Edwards, Jack D Sobel, et al.
Mbio|August 24, 2017
Pharmacodynamics of the Orotomides against <i>Aspergillus fumigatus</i>: New Opportunities for Treatment of Multidrug-Resistant Fungal DiseaseWilliam W Hope, Laura McEntee, Joanne Livermore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2002
Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective studyElias J Anaissie, Shawna L Stratton, M Cecilia Dignani, et al.
The Lancet. Infectious Diseases|January 22, 2013
A comprehensive regulatory framework to address the unmet need for new antibacterial treatmentsJohn H Rex, Barry I Eisenstein, Jeff Alder, et al.
The Lancet. Infectious Diseases|September 28, 2013
Addressing the need for new antibacterials--authors' replyJohn H Rex, Barry I Eisenstein, Jeff Alder, et al.
Medical Mycology|February 20, 2026
Rhino-sino-orbital and/or central nervous system infections due to Lomentospora prolificans and Scedosporium spp. in onco-haematology patientsEnric Sastre-Escolà, Michelle K Yong, Shio Yen Tio, et al.
The Journal of Infectious Diseases|January 17, 2019
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial PneumoniaGeorge H Talbot, Anita Das, Stephanie Cush, et al.
Pageof 10